InvestorsHub Logo
Followers 23
Posts 2036
Boards Moderated 0
Alias Born 12/06/2017

Re: oldmusky post# 143710

Wednesday, 09/15/2021 11:41:58 AM

Wednesday, September 15, 2021 11:41:58 AM

Post# of 144814
It would be great if PMCB could or would be able to do that BUT that is not what PMCB is working on. Take a look at what PMCB is working on:
Live Cell Encapsulation Technology
The Cell-in-a-Box® live cell encapsulation technology employed by PharmaCyte is a “platform” upon which treatments for different diseases may be built. This technology encloses live cells in protective “capsules” about the size of the head of a pin. The capsules are designed to allow blood to enter and nourish the living cells inside them. The live cells thrive while the capsules are in the body. But the capsules are also designed to protect the live cells from attack by the body’s immune system. The live cells are too large to escape from the capsules, and the body’s immune system cells are too large to enter the capsules and destroy them. PharmaCyte is using this technology to develop unique therapies for various forms of cancer and for Type 1 diabetes and insulin dependent Type 2 diabetes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News